133 related articles for article (PubMed ID: 22958153)
21. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis.
Compare D; Rocco A; Liguori E; D'Armiento FP; Persico G; Masone S; Coppola-Bottazzi E; Suriani R; Romano M; Nardone G
J Clin Pathol; 2011 Aug; 64(8):677-82. PubMed ID: 21617174
[TBL] [Abstract][Full Text] [Related]
22. Recent knowledge of the relationship between Helicobacter pylori and gastric cancer and recent progress of gastroendoscopic diagnosis and treatment for gastric cancer.
Kato M; Asaka M
Jpn J Clin Oncol; 2010 Sep; 40(9):828-37. PubMed ID: 20736219
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Helicobacter pylori and prevention of gastric cancer.
Cheung TK; Wong BC
J Dig Dis; 2008 Feb; 9(1):8-13. PubMed ID: 18251788
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of Helicobacter pylori.
Yamamoto K; Kato M; Takahashi M; Haneda M; Shinada K; Nishida U; Yoshida T; Sonoda N; Ono S; Nakagawa M; Mori Y; Nakagawa S; Mabe K; Shimizu Y; Moriya J; Kubota K; Matsuno Y; Shimoda T; Watanabe H; Asaka M
Helicobacter; 2011 Jun; 16(3):210-6. PubMed ID: 21585606
[TBL] [Abstract][Full Text] [Related]
25. Regression of precancerous epithelial alteration in patients with Helicobacter pylori chronic gastritis.
Micu G; Stăniceanu F; Zurac S; Popp C; Bastian A; Grămada E; Tebeica T; Tudose I; Mateescu R; Voiosu R
Rom J Intern Med; 2010; 48(1):89-99. PubMed ID: 21180246
[TBL] [Abstract][Full Text] [Related]
26. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific.
Fox JG; Rogers AB; Ihrig M; Taylor NS; Whary MT; Dockray G; Varro A; Wang TC
Cancer Res; 2003 Mar; 63(5):942-50. PubMed ID: 12615707
[TBL] [Abstract][Full Text] [Related]
28. Gastric cancer: clinical aspects, epidemiology and molecular background.
Bornschein J; Rokkas T; Selgrad M; Malfertheiner P
Helicobacter; 2011 Sep; 16 Suppl 1():45-52. PubMed ID: 21896085
[TBL] [Abstract][Full Text] [Related]
29. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics.
Yoon H; Kim N; Lee HS; Shin CM; Park YS; Lee DH; Jung HC; Song IS
Helicobacter; 2011 Oct; 16(5):382-8. PubMed ID: 21923684
[TBL] [Abstract][Full Text] [Related]
32. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
[TBL] [Abstract][Full Text] [Related]
33. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer.
Kim CG; Choi IJ; Lee JY; Cho SJ; Nam BH; Kook MC; Hong EK; Kim YW
J Gastroenterol Hepatol; 2009 Mar; 24(3):469-74. PubMed ID: 19067779
[TBL] [Abstract][Full Text] [Related]
34. Review article: Helicobacter pylori eradication for the prevention of gastric cancer.
De Vries AC; Kuipers EJ
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():25-35. PubMed ID: 18081646
[TBL] [Abstract][Full Text] [Related]
35. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
36. Effect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation.
Ierardi E; Francavilla R; Panella C
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):470-5. PubMed ID: 9494859
[TBL] [Abstract][Full Text] [Related]
37. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
38. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
Uemura N; Mukai T; Okamoto S; Yamaguchi S; Mashiba H; Taniyama K; Sasaki N; Haruma K; Sumii K; Kajiyama G
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):639-42. PubMed ID: 9264278
[TBL] [Abstract][Full Text] [Related]
39. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults.
Kikuchi S; Crabtree JE; Forman D; Kurosawa M
Am J Gastroenterol; 1999 Dec; 94(12):3455-9. PubMed ID: 10606302
[TBL] [Abstract][Full Text] [Related]
40. Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised?
Lee SY
J Gastroenterol Hepatol; 2012 Feb; 27(2):200-11. PubMed ID: 22098099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
